![Michael Rogawski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Rogawski
Consulente / Consigliere presso XENON PHARMACEUTICALS INC.
Profilo
Michael A Rogawski is the founder of Marinus Pharmaceuticals, Inc., Epalex Corp.
He currently serves on the Scientific Advisory Board for Zogenix, Inc., Xenon Pharmaceuticals, Inc., and Catalio Capital Management LP.
He previously served on the Scientific Advisory Board for Aquestive Therapeutics, Inc., Zynerba Pharmaceuticals, Inc., and GW Pharmaceuticals Ltd.
He obtained his doctorate degree from Yale University.
Posizioni attive di Michael Rogawski
Società | Posizione | Inizio |
---|---|---|
XENON PHARMACEUTICALS INC. | Consulente / Consigliere | - |
ZOGENIX, INC. | Consulente / Consigliere | - |
Catalio Capital Management LP
![]() Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Consulente / Consigliere | - |
Epalex Corp.
![]() Epalex Corp. Miscellaneous Commercial ServicesCommercial Services Epalex Corp. engages in the development of novel treatments for migraine and epilepsy. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. The firm also develops transformational products for seizure prophylaxis in patients suffering from primary generalized epilepsies. The company was founded Randall B. Murphy and is headquartered in Palo Alto, CA. | Fondatore | - |
Precedenti posizioni note di Michael Rogawski
Società | Posizione | Fine |
---|---|---|
ZYNERBA PHARMACEUTICALS, INC. | Consulente / Consigliere | 10/10/2023 |
AQUESTIVE THERAPEUTICS, INC. | Consulente / Consigliere | - |
GW PHARMACEUTICALS PLC | Consulente / Consigliere | - |
MARINUS PHARMACEUTICALS, INC. | Fondatore | - |
Formazione di Michael Rogawski
Yale University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
MARINUS PHARMACEUTICALS, INC. | Health Technology |
XENON PHARMACEUTICALS INC. | Health Technology |
ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
AQUESTIVE THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
Catalio Capital Management LP
![]() Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
GW Pharmaceuticals Ltd.
![]() GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Zogenix, Inc.
![]() Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Epalex Corp.
![]() Epalex Corp. Miscellaneous Commercial ServicesCommercial Services Epalex Corp. engages in the development of novel treatments for migraine and epilepsy. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. The firm also develops transformational products for seizure prophylaxis in patients suffering from primary generalized epilepsies. The company was founded Randall B. Murphy and is headquartered in Palo Alto, CA. | Commercial Services |
- Borsa valori
- Insiders
- Michael Rogawski